Cajal Neuroscience

Seattle, United States

Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.

Nov 2022

Series A

Biotechnology Neuroscience Pharmaceutical Therapeutics

Top Investors

Lux CapitalTwo Sigma VenturesBristol-Myers SquibbAlexandria Venture InvestmentsEvotec

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cajal Neuroscience

Who are Cajal Neuroscience's investors?

Cajal Neuroscience's investors include Lux Capital, Two Sigma Ventures, Bristol-Myers Squibb, Alexandria Venture Investments, Evotec.

Where is Cajal Neuroscience headquartered?

Cajal Neuroscience is headquartered in Seattle, United States.

What does Cajal Neuroscience do?

Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.

What stage is Cajal Neuroscience at?

Cajal Neuroscience is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 29, 2022.

MLA

"Cajal Neuroscience — Funding & Investors." VCBacked, November 29, 2022, https://www.vcbacked.co/company/cajal-neuroscience. Accessed July 1, 2026.

APA

VCBacked. (2022). Cajal Neuroscience — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/cajal-neuroscience

Wikipedia (cite web)

{{cite web |title=Cajal Neuroscience — Funding & Investors |url=https://www.vcbacked.co/company/cajal-neuroscience |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 29, 2022.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.